Reconstructive challenge of dermatofibrosarcoma protuberans in the female breast by Tae Hwan Park et al.
CASE REPORT Open Access
Reconstructive challenge of dermatofibrosarcoma
protuberans in the female breast
Tae Hwan Park, Sang Won Seo, June Kyu Kim, Choong Hyun Chang*
Abstract
Dermatofibrosarcoma protuberans is an uncommon locally aggressive malignant neoplasm that most frequently
appears in the trunk, followed by the extremities, head, and neck. But occurrence in the breast is extremely rare.
We present a case of a 28-year-old woman, who had a history of trauma 5 years previously and excision 1 year
before presentation at our clinic. We performed wide excision, together with microscopic and
immunohistochemical analysis. No postoperative oncologic treatment was used and she remains disease-free
1 year after the surgery without any tumor recurrence. Here, we report a case of dermatofibrosarcoma protuberans
in the female breast and present a detailed discussion of the diagnosis and treatment with reference to available
literatures.
Background
Dermatofibrosarcoma protuberans (DFSP) is an uncom-
mon, slow-growing, low-grade sarcoma of putative der-
mal fibroblastic origin [1]. DFSP was first described by
Darier and Ferrand in 1924 and was referred to as a
progressive and recurrent dermatofibroma. It was later
officially termed “dermatofibrosarcoma protuberans” by
Hoffmann in 1925 [2].
DFSP is a clinically challenging neoplasm because it is
characterized by a high recurrence rate with a high pro-
pensity for local invasion. In addition, it is difficult to
make a correct preoperative diagnosis because DFSP is
often left untreated for several years, probably due to its
benign appearance and initial indolent behaviour.
Our case highlights two specific features. First, under-
standing the natural history of this entity is crucial even
though there are potential difficulties in the diagnosis of
DFSP owing to its rarity. Second, reconstruction for aes-
thetic purpose can be delayed since the presence of a
flap after immediate reconstruction may prevent detec-
tion of the local recurrence and better aesthetic out-
comes can be achieved with delayed procedure.
Case presentation
A 28-year-old woman presented with a slow growing
pigmented protruding mass in the medial lower
quadrant of her left breast. She had a history of trauma
5-years previously, after which, the mass rapidly grew
bigger and became more pigmented. Aware of these
changes, she underwent local excision of the mass in
another hospital a year before presentation in our clinic
and was told that the mass was a benign tumor without
being provided with a specific diagnosis. There were no
abnormal laboratory findings and her family history and
medical history were unremarkable except for the lesion
that was excised a year ago. On gross inspection and
palpation, we noticed a 2 cm × 1 cm smooth mobile
keloid-like reddish mass surrounded by a 3 cm × 2 cm
brownish plaque-like cutaneous thickening in the medial
lower quadrant, at the 7 o’clock position of her left
breast (Figure 1). On physical examination, the lesion
was not tender and no regional lymph nodes were pal-
pated. Since the clinical findings were suggestive of
benign breast disease and the patient refused further
evaluation, we did not perform conventional mammo-
graphy or ultrasonography.
We performed a wide excision of the breast lesion
with a 3 cm margin and a frozen section under general
anesthesia and the defect was closed primarily.
The gross pathology of the specimens showed a gray-
ish white ill-demarcated soft tissue mass measuring 3.8
cm × 3.1 cm × 1.1 cm (Figure 2, 3).
On histological examination, a storiform pattern of
spindle cells infiltrating into subcutaneous tissue above
the mammary gland was noticed (Figure 4, 5, 6). There
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was only mild mitotic activity (2-3 per 10 high-power
fields) and no resection margin involvement.
On immunohistochemical examination, the lesion
stained positive for CD34 (Figure 7) and locally positive
for SMA, and negative for CD68 and S-100 protein
(Figure 8). The mass was eventually diagnosed as DFSP.
The patient did not undergo any postoperative oncolo-
gic treatment. Delayed reconstruction is scheduled for at
least 2 years after the wide excision unless recurrence or
metastasis occurs. Postoperative follow-up has been
maintained up to the present time, 1 year after the
operation, without any tumor recurrence.
Discussion
DFSP accounts for approximately 6% of all soft tissue
sarcomas with an estimated incidence of 0.8 cases per
million per year [3].
DFSP occurs most frequently between the second to
fourth decades of life and males are more frequently
affected. Most cases of DFSP present as a plaque-like
cutaneous thickening and generally increase in size at a
slow rate for a considerable period of time, thus they
are often regarded as a benign tumor before more rapid
growth ensues [4]. For this reason, it is usually regarded
lightly by patients as well as physicians leading to
delayed and often ‘wait and watch’ approach. Differential
diagnoses include dermatofibromas, keloid, or morphea
Figure 1 Preoperative appearance of the patient. A 2 × 1 cm
reddish mass with 3 × 2 cm brownish plaque-like cutaneous
thickening.
Figure 2 Gross specimen. Outer surface of ill-defined gray rubbery
mass.
Figure 3 Gross specimen. Cross section of the mass.
Figure 4 Microscopic examination. Several atypical cell with mitosis
in the relatively blend spindle cells was noticed (H&E stain, × 400).
Figure 5 Microscopic examination. There is characteristic
infiltration of fibroblast between fat cells in subcutaneous tissue
(H&E stain, × 200).
Figure 6 Microscopic examination. Infiltrative border in dermis
was observed (H&E stain, × 100).
Park et al. World Journal of Surgical Oncology 2011, 9:1
http://www.wjso.com/content/9/1/1
Page 2 of 4
in early lesions, or cutaneous metastasis, malignant lym-
phoma, and Kaposi sarcoma in advanced states [5].
Tohru et al. and Hisaki et el. place a small value on
mammography and ultrasonography in preoperative
diagnosis of DFSP in the breast[6]. MRI can give infor-
mation about the deep tissue involvement, especially in
patients with large recurrent tumors, whereas, CT has
limited value except defining bone involvement. Fine-
needle aspiration(FNA) may be useful in establishing a
nonspecific pathology in patients with previously treated
tumors [7]. However, FNA is not always feasible because
obtaining sufficient tissue is difficult for most untreated
tumors. Large core needle biopsy or excisional biopsy
can help to provide a correct diagnosis [3]. The charac-
teristic findings are interlacing spindle-shaped tumor
cells in the dermis and subcutaneous fat layer that form
definite bands that interweave or radiate like spokes of a
wheel, forming a so-called ‘cartwheel’ or ‘storiform’
pattern.
Immunohistochemical markers are highly sensitive for
DFSP. In particular, CD34 is a useful marker that allows
differentiation of DFSP tumor cells from normal stroma
cells. DFSP generally stains positive for CD34 and nega-
tive for S-100 protein, factor XIIIa [8].
Many authors share the same opinion that complete
surgical excision with wide, pathologically negative mar-
gins is the optimal treatment for primary or recurrent
DFSP. Traditionally, the recommended treatment has
been wide surgical excision with gross margins of at
least 3 cm [4,9,10]. In 1967, McPeak et al concluded
that even with this margin the recurrence rate was 10%
(8 of 82)[10]. As many authors believe that the risk of
metastasis is increased in cases with several incompletely
excised recurrent tumors,[11] surgeons should focus on
complete tumor excision to prevent local recurrence,
metastasis, and reoperations. Since wide excision usually
causes noteworthy distortion and leaves patients with
significant cosmetic problems, especially in the female
breast, reconstructive procedure is required in almost
every instances. In cases in which wide excision and
primary flap reconstructions are performed simulta-
neously, there should be no doubt as to the adequacy of
the excision, because the presence of a flap may prevent
detection of the local recurrence. In general, the recon-
structive challenge in DFSP such as in the trunk, extre-
mities, head and neck comprises of large tissue defects
which need covering when vital structures are exposed.
In cases of the breast, however, the challenge lay in
being able to create a near-normal-looking breasts with
good symmetry and color match.
Mohs microscopic surgery (MMS) has emerged as an
alternative approach allowing immediate microscopic
examination of the margins. However, MMS requires
considerable training, a specialized team, multiple
stages [12].
Adjuvant radiation therapy can be administered if
margins are positive or very close to the tumor after
maximal resection.
Recently, the tyrosine kinase inhibitor Imatinib, was
shown to induce regression of advanced DFSP when it
is impossible to obtain surgical margins. According to a
review of Mizutani et el., imatinib inhibited the growth
of metastatic lung lesions in a patient with DFSP [13].
In conclusion, although DFSP in the breast is rare,
clinical suspicion is of paramount importance for an
accurate diagnosis and vigilant follow-up for the pig-
mented lesion is necessary.
Even when the growth pattern of a lesion does have
the typical characteristics of a benign lesion, a tissue
biopsy is recommended. Conventional radiologic exam-
inations are of limited value whereas histological and
immunohistochemical confirmation is useful. The opti-
mal treatment is wide excision with a sufficient surgi-
cal margin. In cases of DFSP of the breast, delayed
reconstructive procedure can be considered since pri-
mary closure of the defect is not difficult due to suffi-
cient soft tissue of the breast. Any concern about
adequacy of complete excision, a large lesion with a
negative margin, and a patient’s severe anxiety about
recurrence after excision can be considered as indica-
tions for delayed reconstruction (Figure 9). In addition,
long-term postoperative follow up beyond several years
is mandatory.
Figure 7 Immunohistochemical examination. Tumor stained
positive for CD34.
Figure 8 Immunohistochemical examination. Tumor stained
negative for S-100 protein.
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Figure 9 Indications for delayed reconstruction of breast DFSP.
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